These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 10976650)
1. An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients. Kenney K; Brechtel C; Takahashi H; Kurohara K; Anderson P; Gibbs CJ Ann Neurol; 2000 Sep; 48(3):395-8. PubMed ID: 10976650 [TBL] [Abstract][Full Text] [Related]
2. [Diagnostic usefulness of the determination of protein 14-3-3 in cerebrospinal fluid in Creutzfeld-Jakob disease]. Sáiz A; Marín C; Tolosa E; Graus F Neurologia; 1998; 13(7):324-8. PubMed ID: 9810794 [TBL] [Abstract][Full Text] [Related]
3. [Cerebrospinal fluid diagnosis of Creutzfeldt-Jakob disease]. Bernheimer H; Gatterbauer B; Radbauer C; Budka H Wien Med Wochenschr; 1998; 148(4):96-100. PubMed ID: 9611349 [TBL] [Abstract][Full Text] [Related]
4. Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid. Collins S; Boyd A; Fletcher A; Gonzales M; McLean CA; Byron K; Masters CL J Clin Neurosci; 2000 May; 7(3):203-8. PubMed ID: 10833616 [TBL] [Abstract][Full Text] [Related]
5. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Geschwind MD; Martindale J; Miller D; DeArmond SJ; Uyehara-Lock J; Gaskin D; Kramer JH; Barbaro NM; Miller BL Arch Neurol; 2003 Jun; 60(6):813-6. PubMed ID: 12810484 [TBL] [Abstract][Full Text] [Related]
6. [Creutzfeldt-Jakob disease: diagnostic value of protein 14-3-3 and neuronal specific enolase assay in cerebrospinal fluid]. Brandel JP; Beaudry P; Delasnerie-Lauprêtre N; Laplanche JL Rev Neurol (Paris); 1999 Feb; 155(2):148-51. PubMed ID: 10226319 [TBL] [Abstract][Full Text] [Related]
7. [CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practice]. Blennow K; Lind B; Andersson E; Andreasen N Lakartidningen; 2001 May; 98(20):2446-51. PubMed ID: 11433975 [TBL] [Abstract][Full Text] [Related]
8. Interleukin 4 and interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Stoeck K; Bodemer M; Ciesielczyk B; Meissner B; Bartl M; Heinemann U; Zerr I Arch Neurol; 2005 Oct; 62(10):1591-4. PubMed ID: 16216944 [TBL] [Abstract][Full Text] [Related]
9. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. Hsich G; Kenney K; Gibbs CJ; Lee KH; Harrington MG N Engl J Med; 1996 Sep; 335(13):924-30. PubMed ID: 8782499 [TBL] [Abstract][Full Text] [Related]
10. [Clinical algorithm for cerebrospinal fluid test of 14-3-3 protein in diagnosis of Creutzfeldt-Jacob disease]. Lemstra AW; van Meegen M; Baas F; van Gool WA Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1467-71. PubMed ID: 11503317 [TBL] [Abstract][Full Text] [Related]
11. Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Saiz A; Graus F; Dalmau J; Pifarré A; Marin C; Tolosa E Ann Neurol; 1999 Nov; 46(5):774-7. PubMed ID: 10970247 [TBL] [Abstract][Full Text] [Related]
12. A novel binding assay for detection of 14-3-3 protein in cerebrospinal fluid from Creutzfeldt-Jakob patients. Leuck J; Peoch K; Laplanche JL; Grabar E; Müller WE; Schröder HC Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1291-6. PubMed ID: 11075958 [TBL] [Abstract][Full Text] [Related]
13. Determination of 14-3-3 protein levels in cerebrospinal fluid from Creutzfeldt-Jakob patients by a highly sensitive capture assay. Peoc'h K; Schröder HC; Laplanche J; Ramljak S; Müller WE Neurosci Lett; 2001 Apr; 301(3):167-70. PubMed ID: 11257424 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease. Van Everbroeck B; Boons J; Cras P Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527 [TBL] [Abstract][Full Text] [Related]
15. 14-3-3 protein levels and isoform patterns in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients in the progressive and terminal stages. Shiga Y; Wakabayashi H; Miyazawa K; Kido H; Itoyama Y J Clin Neurosci; 2006 Jul; 13(6):661-5. PubMed ID: 16815706 [TBL] [Abstract][Full Text] [Related]
16. Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease. Wong BS; Green AJ; Li R; Xie Z; Pan T; Liu T; Chen SG; Gambetti P; Sy MS J Pathol; 2001 May; 194(1):9-14. PubMed ID: 11329135 [TBL] [Abstract][Full Text] [Related]
17. Autopsy-proven Creutzfeldt-Jakob disease in a patient with a negative 14-3-3 assay and nonspecific EEG and MRI. Donahue JE; Hanna PA; Hariharan S Neurol Sci; 2004 Feb; 24(6):411-3. PubMed ID: 14767688 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease. Blennow K; Johansson A; Zetterberg H Int J Mol Med; 2005 Dec; 16(6):1147-9. PubMed ID: 16273298 [TBL] [Abstract][Full Text] [Related]
19. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease. Satoh K; Shirabe S; Tsujino A; Eguchi H; Motomura M; Honda H; Tomita I; Satoh A; Tsujihata M; Matsuo H; Nakagawa M; Eguchi K Dement Geriatr Cogn Disord; 2007; 24(3):207-12. PubMed ID: 17690553 [TBL] [Abstract][Full Text] [Related]
20. Pro- and anti-inflammatory cytokines in the CSF of patients with Creutzfeldt-Jakob disease. Stoeck K; Bodemer M; Zerr I J Neuroimmunol; 2006 Mar; 172(1-2):175-81. PubMed ID: 16330103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]